Rokea A el-Azhary1, Julia S Lehman2. Show Affiliations » 1. Department of Dermatology, Mayo Clinic, Rochester, MN, USA. elazhary.rokea2@mayo.edu. 2. Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
Abstract
Entities: Disease
Mesh： See more » Adalimumab/adverse effectsAged, 80 and overAnti-Inflammatory Agents/adverse effectsDermatitis, Exfoliative/chemically inducedDrug Eruptions/etiologyFemaleHumansInfliximab/adverse effectsMaleMiddle AgedTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances： See more » Anti-Inflammatory AgentsTumor Necrosis Factor-alphaInfliximabAdalimumab
Year: 2016 PMID： 26917358 DOI： 10.1111/ijd.13273
Source DB: PubMed Journal: Int J Dermatol ISSN： 0011-9059 Impact factor: 2.736